Publications

Found results: 8799

• Myeloid Ezh2 Deficiency Limits Atherosclerosis Development.

  Neele A E, Chen H J, Gijbels M J J, van der Velden S, Hoeksema M A, Boshuizen M C S, Van den Bossche J, Tool A T, Matlung H L, van den Berg T K, Lutgens E and de Winther M P J. Front Immunol 2020; 11 594603. abstract
• Rapid, Sensitive, and Specific Severe Acute Respiratory Syndrome Coronavirus 2 Detection: A Multicenter Comparison Between Standard Quantitative Reverse-Transcriptase Polymerase Chain Reaction and CRISPR-Based DETECTR.

  Brandsma E, Verhagen H J M P, van de Laar T J W, Claas E C J, Cornelissen M and van den Akker E. J Infect Dis 2021; 223 (2): 206-213. abstract
• CD8 and CD4 T Cell Populations in Human Kidneys.

  van der Putten C, Remmerswaal E B M, Terpstra M L, van der Bom N D, Kers J, Ten Berge I J M, Geerlings S E, van Lier R A W, Bemelman F J and van Aalderen M C. Cells 2021; 10 (2): . abstract
• N-glycan mediated shielding of ADAMTS13 prevents binding of pathogenic autoantibodies in immune-mediated TTP.

  Ercig B, Gomes Graca N A, Kangro K, Arfman T, Wichapong K, Hrdinova J, Kaijen P, van Alphen F, van den Biggelaar M, Vanhoorelbeke K, Veyradier A, Coppo P, Reutelingsperger C, Nicolaes G A F, Mannik A and Voorberg J. Blood 2021; epub ahead of print FEb 5, 2020. abstract
• Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands.

  Luken J S, Folman C C, Lukens M V, Meekers J H, Ligthart P C, Schonewille H, Zwaginga J J, Janssen M P, van der Schoot C E, van der Bom J G and de Haas M. Transfusion 2021; epub ahead of print feb 2, 2021. abstract
• Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders.

  Atiq F, Saes J L, Punt M C, van Galen K P M, Schutgens R E G, Meijer K, Cnossen M H, Laros-Van Gorkom B A P, Peters M, Nieuwenhuizen L, Kruip M J H A, de Meris J, van der Bom J G, van der Meer F J M, Fijnvandraat K, Kruis I C, van Heerde W L, Eikenboom H C J, Leebeek F W G, Schols S E M and For the WiN RBiN and Tin study groups. EClinicalMedicine 2021; 32 100726. abstract
• Healthy cells functionally present TAP-independent SSR1 peptides: implicattions for selection of clinically relevant antigens.

  de Waard A A, Verkerk T, Hoefakker K, van der Steen D M, Jongsma M L M, Melamed Kadosh D, Bliss S, de Ru A H, Admon A, van Veelen P A, Griffioen M, Heemskerk M H M and Spaapen R M. iScience 2021; 24 (2): 102051. abstract
• ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group.

  Goel R, Bloch E M, Pirenne F, Al-Riyami A Z, Crowe E, Dau L, Land K, Townsend M, Jecko T, Rahimi-Levene N, Patidar G, Josephson C D, Arora S, Vermeulen M, Vrielink H, Montemayor C, Oreh A, Hindawi S, van den Berg K, Serrano K, So-Osman C, Wood E, Devine D V, Spitalnik S L and Group Isbt Covid- Working. Vox Sang 2021; epub ahead of print FEb 12, 2021. abstract
• Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.

  Koutsakos M, Rowntree L C, Hensen L, Chua B Y, van de Sandt C E, Habel J R, Zhang W, Jia X, Kedzierski L, Ashhurst T M, Putri G H, Marsh-Wakefield F, Read M N, Edwards D N, Clemens E B, Wong C Y, Mordant F L, Juno J A, Amanat F, Audsley J, Holmes N E, Gordon C L, Smibert O C, Trubiano J A, Hughes C M, Catton M, Denholm J T, Tong S Y, Doolan D L, Kotsimbos T C, Jackson D C, Krammer F, Godfrey D I, Chung A W, King N J, Lewin S R, Wheatley A K, Kent S J, Subbarao K, McMahon J, Thevarajan I, Nguyen T H, Cheng A C and Kedzierska K. Cell Rep Med 2021; 100208. abstract
• De bloedveiligheid in Nederland [Blood safety in the Netherlands: prevention of blood-transmitted infections].

  Danovic F, Lieshout-Krikke R W, Koopman R W W and van Kraaij M G J. Ned Tijdschr Geneeskd 2020; 164 . abstract
• Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use.

  Zeerleder S, Engel R, Zhang T, Roem D, van Mierlo G, Wagenaar-Bos I, van Ham S M, Wuhrer M, Wouters D and Jongerius I. Pharmaceuticals (Basel) 2021; 14 (1): . abstract
• Back to base pairs: What is the genetic risk for red bloodcell alloimmunization?.

  Gerritsma J J, Oomen I, Meinderts S, van der Schoot C E, Biemond B J, van der Bom J G, Fijnvandraat K and consortium Score. Blood Rev 2021; 100794. abstract
• CD14+ monocytes repress gamma globin expression at early stages of erythropoiesis.

  Heshusius S, Heideveld E, von Lindern M and van den Akker E. Sci Rep 2021; 11 (1): 1507. abstract
• Comprehensive evaluation of microneedle-based intradermal adalimumab delivery versus subcutaneous administration: results of a randomized controlled trial.

  Jacobse J, Ten Voorde W, Tandon A, Romeijn S G, Grievink H W, van der Maaden K, van Esdonk M J, Moes Djar, Loeff F, Bloem K, de Vries A, Rispens T, Wolbink G, de Kam M, Ziagkos D, Moerland M, Jiskoot W, Bouwstra J, Burggraaf J, Schrier L, Rissmann R and Ten Cate R. Br J Clin Pharmacol 2021; epub ahead of print Jan 5, 2021. abstract
• Recommendations for clinical laboratory testing for protein S deficiency: Communication from the SSC committee plasma coagulation inhibitors of the ISTH.

  Marlar R A, Gausman J N, Tsuda H, Rollins-Raval M A and Brinkman H J M. J Thromb Haemost 2021; 19 (1): 68-74. abstract
• Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH.

  Brinkman H J M, Ahnstrom J, Castoldi E, Dahlback B and Marlar R A. J Thromb Haemost 2021; 19 (1): 281-286. abstract
• Anti-beta2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action.

  Noordermeer T, Molhoek J E, Schutgens R E G, Sebastian S A E, Drost-Verhoef S, van Wesel A C W, de Groot P G, Meijers J C M and Urbanus R T. J Thromb Haemost 2021; epub ahead of print Jan 9, 2021. abstract
• Biological stratification of clinical disease courses in childhood immune thrombocytopenia.

  Schmidt D E, Heitink-Polle K M J, Mertens B, Porcelijn L, Kapur R, van der Schoot C E, Vidarsson G, van der Bom J G, Bruin M C A and de Haas M. J Thromb Haemost 2021; epub ahead of print Jan 1, 2021. abstract
• Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy.

  Kuitwaard K, van Doorn P A, Bengrine T, van Rijs W, Baas F, Nagelkerke S Q, Kuijpers T W, Fokkink W R, Bunschoten C, Broers M C, Willemsen S P, Jacobs B C and Huizinga R. Eur J Neurol 2021; epub ahead of print Jan 18, 2021. abstract
• Specific and Sensitive Detection of Neuroblastoma mRNA Markers by Multiplex RT-qPCR.

  van Zogchel L M J, Zappeij-Kannegieter L, Javadi A, Lugtigheid M, Gelineau N U, Lak N S M, Zwijnenburg D A, Koster J, Stutterheim J, van der Schoot C E and Tytgat G A M. Cancers (Basel) 2021; 13 (1): . abstract